MedTrace Logo

PLatform Study for INTracerebral Haemorrhage (PLINTH): Community-based Feasibility Study

NCT06078020 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 169

Last updated 2026-07-28

No results posted yet for this study

Summary

The goal of this observational study is to answer three uncertainties about the design of a platform study for adults with stroke due to intracerebral haemorrhage.

The main things the investigators aim to find out are:

* The acceptability of a platform trial and its comparisons to brain haemorrhage survivors or their carers, and their clinicians.
* Estimates of eligibility, willingness to participate, diversity, representativeness, adherence, retention, data completion, and event rates of intermediate and clinical outcomes over time for each comparison.
* The most efficient platform trial design considering the findings of this feasibility study.

Participants, or their welfare guardian, welfare attorney, or nearest relative will:

* Watch a video informing them about the study
* Read written information about the study
* Provide informed consent
* Permit collection of demographic and clinical details
* Provide information in interviews at \~3 and \~14 days after the onset of the stroke

Conditions

  • Cerebral Hemorrhage

Interventions

OTHER

Interview

Semi-structured interview to assess understanding and acceptability at 3+/-2 and 14+/-7 days after consent

Sponsors & Collaborators

  • University of the West of Scotland

    collaborator OTHER

  • University of Nottingham

    collaborator OTHER

  • University of Edinburgh

    lead OTHER

Principal Investigators

  • Rustam AS Salman, MA PhD FRCPE · University of Edinburgh

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2025-06-30
Completion
2025-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06078020 on ClinicalTrials.gov